Chai Discovery's banner

Chai Discovery

@chaidiscovery • 6,866 subscribers

Shorts

We’ve raised $400M at a $3.8B valuation to further advance AI-driven molecular design. The round was led by Index Ventures, alongside @KleinerPerkins, @Sequoia, DIMENSION, and others.

We’ve raised $400M at a $3.8B valuation to further advance AI-driven molecular design. The round was led by Index Ventures, alongside @KleinerPerkins, @Sequoia, DIMENSION, and others.

85,409 просмотров

We’re delighted to announce our third agreement this week, this time a collaboration with argenx. argenx has built one of biotechnology’s most productive antibody engines. We’ll be putting Chai’s frontier molecular design platform into the hands of their scientists.

We’re delighted to announce our third agreement this week, this time a collaboration with argenx. argenx has built one of biotechnology’s most productive antibody engines. We’ll be putting Chai’s frontier molecular design platform into the hands of their scientists.

35,191 просмотров

Today we’re releasing Chai-1r, an updated version of Chai-1 with full support for restraints. Prompting Chai-1r with prior structural knowledge can boost accuracy by >2x.

Today we’re releasing Chai-1r, an updated version of Chai-1 with full support for restraints. Prompting Chai-1r with prior structural knowledge can boost accuracy by >2x.

30,508 просмотров

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇

We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇

713,994 просмотров • 1 год назад

Today, we’re releasing new data showing that Chai-2 can design antibodies against challenging targets with atomic precision. >86% of our designs possess industry-standard drug-quality properties without any optimization. Thread👇

Today, we’re releasing new data showing that Chai-2 can design antibodies against challenging targets with atomic precision. >86% of our designs possess industry-standard drug-quality properties without any optimization. Thread👇

266,817 просмотров • 10 месяцев назад

We raised $130M in Series B funding at a $1.3B valuation to build the computer aided design suite for molecules. The round was led by General Catalyst & Oak HC/FT along with existing investors Thrive Capital, OpenAI, DIMENSION, Neo, Lachy Groom, Menlo Ventures, SV Angel, and Yosemite. We're also joined by new investors including Emerson Collective and Glade Brook.

We raised $130M in Series B funding at a $1.3B valuation to build the computer aided design suite for molecules. The round was led by General Catalyst & Oak HC/FT along with existing investors Thrive Capital, OpenAI, DIMENSION, Neo, Lachy Groom, Menlo Ventures, SV Angel, and Yosemite. We're also joined by new investors including Emerson Collective and Glade Brook.

115,337 просмотров • 9 месяцев назад

Больше нет контента для загрузки